Carina Biotech

📍 Adelaide, Australia🗓 Founded 2016👥 16 employees💰 Last funded Jan 2021
Biotechnology Research🌐 carinabiotech.com
Website LinkedIn
Carina Biotech An Australian clinical stage immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. Carina are working towards producing broad-spectrum CAR-T therapies that can be used to treat multiple solid cancers yet are patient-specific and result in little, if any, off-cancer damage. Using its proprietary platforms, Carina is also developing technologies to improve access to, and infiltration of, solid cancers, and to enhance CAR-T cell manufacturing. We are working to… 1. Expand the clinical indications for T cell therapies 2. Improve the commercial viability of T cell therapies by developing supporting technologies that make T cell therapies more effective or economically viable Headquartered in Adelaide, South Australia, Carina has strong T cell R&D capability across a network of research providers and collaborators including leading scientists at the UniSA, the Womens & Childrens Hospital in Adelaide, the University of Adelaide, the Royal Prince Alfred Hospital in NSW and the Seattle Childrens Hospital in the United States.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Australia
1
Frequently asked questions
Who invested in Carina Biotech?
Carina Biotech has 1 investors on record on gritt.io, 1 mid-stage.
When did Carina Biotech last raise funding?
The most recent investment in Carina Biotech recorded on gritt.io was in January 2021.
When was Carina Biotech founded?
Carina Biotech was founded in 2016.
What industry is Carina Biotech in?
Carina Biotech operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Carina Biotech based?
Carina Biotech is headquartered in Adelaide, Australia.